MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
245 hedge funds and large institutions have $8.55B invested in Mirati Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 88 increasing their positions, 91 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $9.15B → $8.55B (-$601M)
25% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 52
Holders
245
Holding in Top 10
12
Calls
$97.2M
Puts
$40.7M
Top Buyers
| 1 | +$148M | |
| 2 | +$66.9M | |
| 3 | +$62.9M | |
| 4 |
Millennium Management
New York
|
+$59.7M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$53.9M |
Top Sellers
| 1 | -$250M | |
| 2 | -$49.4M | |
| 3 | -$46.6M | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$43.7M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$42.4M |